MEDICINE & HEALTHRecent research analyzing blood donation samples since July 2020 shows that as of May 2021, 4 out of 5 American adults over the age of 16 have developed antibodies via infection or vaccine.
Scientists identified antibodies detected from those who already recovered that could pave the way for developing a pan-COVID vaccine, which can neutralize different viruses.
A new study on COVID-19 suggests that antibodies against the coronavirus are active 9 months in people after being infected. Strong evidence of the antibody research were recorded from Vo, a town in Italy that had the most positive cases at the early surge of the pandemic.
A new study finding recently offered the potential of developing drugs for the activation of a pathway to improve the efficacy of vaccines, including COVID-19 vaccines.
Cases of pet owners transmitting COVID-19 infection to their dog or cat have been documented previously although are considered to be an insignificant risk to public health.
Researchers recently analyzed more than a million SARS-CoV-2 genome sequences, an analysis that resulted in the detection of a new COVID-19 Mexican variant spreading not just in Mexico but is also found in Europe.
Researchers at Washington University School of Medicine found that mild cases of COVID-19 still have immune cells in their bodies pumping out antibodies against the virus months after recovering.
Researchers recently developed an Ebola virus vaccine that has shown promise in rabbits and mice. Specifically, what the scientists developed is a new nanoparticle-based shot for protection against the virus.
The Valneva COVID-19 vaccine is said to be reliant against the virus. This shot from the French company, Valneva, has yet to reach completion of his clinical trials.
CHOP researchers recently discovered the genetic mutation responsible for a boy's condition, which prevents him and other patients like him from forming antibodies and B cells to combat infections.
San Diego Zoo's great apes are the first non-humans to be given COVID-19 vaccine. Specifically, 4 orangutans and 5 bonobos got their first shot of the vaccine.
Researchers have developed a potential new nanoparticle-delivered COVID-19 vaccine that has presented strong effectiveness in preclinical illness models.
Britain announced its first six cases of a Brazilian COVID-19 variant infection that ministers had been desperately attempting to keep out of the country.
Recent tests show that there's already mutation in the Covid-19 strain identified as E484K. Recent tests show that there's already mutation in the Covid-19 strain identified as E484K, which was first detected in South Africa.
Researchers from the University of Arizona created a new COVID-19 test that uses a smartphone to analyze saliva samples to detect the novel coronavirus in ten minutes.